1. |
Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on themanagement and treatment of IgG4-related disease.JArthritis Rheumatol, 2015, 67:1688-1699.
|
2. |
Divitia M, Kim SA, Ro Jy. IgG4-related sclerosing disease, an emerging entity: are view ofamulti-system disease. JYonsei Med, 2012, 53:15-34.
|
3. |
林玮, 张文.IgG4相关性疾病.中华临床免疫和变态反应杂志, 2010, 4:307-310.
|
4. |
Kamisawa T, Okamoto A. IgG4-related sclerosing disease. WorldJGastroenterol, 2008, 14:3948-3955.
|
5. |
Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease.JGastroenterol, 2011, 46:277-288.
|
6. |
Zen Y, Inoue D. Kitao A, et al. IgG4-related lung and pleura disease:aclinicopathologic study of 21 cases.JHumpathol, 2012, 43:536-549.
|
7. |
Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013: Ⅲ. Treatment and prognosis of autoimmune pancreatitis. JGastroenterol, 2014, 49:961-970.
|
8. |
Kim HM, Chung MJ, Chung JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.JPancreas, 2010, 39:555-560.
|